← Leaderboards
G Scott Worthen
National Jewish Health
$17,039,709
Attributed
$19,605,625
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,605,625 · 14
By mechanism
R01$14,345,652 · 7
UH3$1,497,963 · 1
UG3$1,443,542 · 1
T32$921,823 · 1
P01$661,539 · 2
R21$446,407 · 1
Top collaborators
- Dongeun Huh4 shared
- Vladimir R Muzykantov3 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Abraham Kupfer$6,680,869
Others in their field
Top investigators on “Neutrophil”
- Charles Nicholas Serhan · Brigham And Women'S Hospital$23,875,763
- Hongbo R Luo · Children'S Hospital Boston$23,323,359
- Tanya N. Mayadas · Brigham And Women'S Hospital$21,795,639
- Victor Nizet · University Of California, San Diego$21,031,691
- J. Edwin Blalock · University Of Alabama At Birmingham$19,196,735
- Robert Fairchild · Cleveland Clinic Lerner Com-Cwru$18,658,323
Research focus
NeutrophilCellsLungInflammationHost DefenseResponseLaboratory MouseInflammatoryLigandsTissuesSurfaceHuman SubjectBacteriaRegulationSignal TransductionMarrowMediatingCxcl5 GeneOrganMitogen Activated Protein KinaseSiteIn VivoIn VitroPneumonia
Grant awards (50)
Dual drug delivery to lung/blood interface in respiratory infections.$721,126
R01 · FY2023 · HL
Dual drug delivery to lung/blood interface in respiratory infections.$726,891
R01 · FY2022 · HL
Dual drug delivery to lung/blood interface in respiratory infections.$742,310
R01 · FY2021 · HL
Lung Host Defense in Microgravity$735,375
UH3 · FY2020 · TR · contact PI
Lung Host Defense in Microgravity$762,588
UH3 · FY2019 · TR · contact PI
Lung Host Defense in Microgravity$657,599
UG3 · FY2018 · TR · contact PI
Lung Host Defense in Microgravity$785,943
UG3 · FY2017 · TR · contact PI
CXC Chemokines and Regulation of Granulopoiesis$418,750
R01 · FY2017 · AI · contact PI
CXC Chemokines and Regulation of Granulopoiesis$418,750
R01 · FY2016 · AI · contact PI
CXC Chemokines and Regulation of Granulopoiesis$418,750
R01 · FY2015 · AI · contact PI
CXC Chemokines and Regulation of Granulopoiesis$418,750
R01 · FY2014 · AI · contact PI
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung$410,375
R01 · FY2014 · HL · contact PI
Training Program in Genome-Environment Interactions in Neonatal Disease$174,745
T32 · FY2014 · HD · contact PI
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung$398,650
R01 · FY2013 · HL · contact PI
CXC Chemokines and Regulation of Granulopoiesis$393,625
R01 · FY2013 · AI · contact PI
Training Program in Genome-Environment Interactions in Neonatal Disease$159,852
T32 · FY2013 · HD · contact PI
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung$418,750
R01 · FY2012 · HL · contact PI
Training Program in Genome-Environment Interactions in Neonatal Disease$190,419
T32 · FY2012 · HD · contact PI
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung$418,750
R01 · FY2011 · HL · contact PI
Training Program in Genome-Environment Interactions in Neonatal Disease$203,121
T32 · FY2011 · HD · contact PI
Neurtophil Homeostasis and Lung Sequestration$411,250
R01 · FY2010 · HL · contact PI
Training Program in Genome-Environment Interactions in Neonatal Disease$193,686
T32 · FY2010 · HD · contact PI
Multi-Dimensional Separation of Bacteria$193,470
R21 · FY2010 · HG · contact PI
Neurtophil Homeostasis and Lung Sequestration$411,250
R01 · FY2009 · HL · contact PI
Multi-Dimensional Separation of Bacteria$252,937
R21 · FY2009 · HG · contact PI
Neurtophil Homeostasis and Lung Sequestration$411,250
R01 · FY2008 · HL · contact PI
Neurtophil Homeostasis and Lung Sequestration$412,500
R01 · FY2007 · HL · contact PI
LPS-induced Neutrophil Accumulation in the Lung$323,423
R01 · FY2007 · HL · contact PI
Growth Factors and Signaling Pathways in Pulmonary Fibr*$608,763
R01 · FY2006 · HL · contact PI
LPS-induced Neutrophil Accumulation in the Lung$333,083
R01 · FY2006 · HL · contact PI
Growth Factors and Signaling Pathways in Pulmonary Fibr*$644,786
R01 · FY2005 · HL
Neutrophil Homeostasis and Lung Sequestration$416,900
R01 · FY2005 · HL
LPS-induced Neutrophil Accumulation in the Lung$341,100
R01 · FY2005 · HL
Growth Factors and Signaling Pathways in Pulmonary Fibr*$642,239
R01 · FY2004 · HL
LPS-induced Neutrophil Accumulation in the Lung$341,100
R01 · FY2004 · HL
Neutrophil Homeostasis and Lung Sequestration$341,100
R01 · FY2004 · HL
Production of Neutrophils from Human Embryonic Stem Cells$75,800
R01 · FY2004 · HL
Growth Factors and Signaling Pathways in PF$651,400
R01 · FY2003 · HL
LPS-induced Neutrophil Accumulation in the Lung$341,756
R01 · FY2003 · HL
Neutrophil Homeostasis and Lung Sequestration$341,100
R01 · FY2003 · HL
Neutrophil Homeostasis and Lung Sequestration$342,225
R01 · FY2002 · HL
LPS-INDUCED NEUTROPHIL ACCUMULATION IN THE LUNG$308,821
R01 · FY2002 · HL
Regulation of myofibroblast phenotype$288,699
P50 · FY2002 · HL
Neutrophil Response to Chemoattractants$220,513
P01 · FY2002 · HL
CC CHEMOKINES AND HUMAN CYTOMEGALOVIRUS PNEUMONITIS$144,400
R01 · FY2002 · HL
LPS-INDUCED NEUTROPHIL ACCUMULATION IN THE LUNG$301,513
R01 · FY2001 · HL
Neutrophil Response to Chemoattractants$220,513
P01 · FY2001 · HL
Regulation of myofibroblast phenotype$0
P01 · FY2001 · HL
LPS-INDUCED NEUTROPHIL ACCUMULATION IN THE LUNG$294,416
R01 · FY2000 · HL
Neutrophil Response to Chemoattractants$220,513
P01 · FY2000 · HL